|
Management
Robert B. Kay, Executive Chairman | Mr. Kay is a principal and Chairman of Seaway Biltmore, Inc., a hotel ownership and management company. Mr. Kay was a founder and senior partner of the New York law firm of Kay Collyer & Boose LLP, with a particular focus on mergers and acquisitions and joint ventures. He received his B.A. from Cornell University's College of Arts & Sciences and his J.D. from New York University Law School. |
Robert L. Erwin, President Mr. Erwin previously led Large Scale Biology Corporation from its founding in 1988 through 2003, including a successful initial public offering in 2000, and continued as non-executive Chairman until 2006. Mr. Erwin recently served as Managing Director of Bio-Strategic Directors LLC providing consulting services to the life sciences industry. He served as Chairman of Icon Genetics AG from 1999 until its acquisition by a subsidiary of Bayer AG in 2006. He is currently Chairman of Novici Biotech, a private biotechnology company and a Director of Resolve Therapeutics, Inc. Mr. Erwin’s non-profit work focuses on applying scientific advances to clinical medicine, especially in the field of oncology. He is co-founder, President and Director of the Marti Nelson Cancer Foundation, and a member of the Research Committee of the American Society of Clinical Oncology. Mr. Erwin received his B.S. degree with Honors in Zoology and an M.S. degree in Genetics from Louisiana State University. |
Geoffrey Schild, Ph.D., CBE, Chief Scientific Officer | Dr. Schild has been involved in setting global standards for quality control of vaccines and has been an active scientific contributor to the World Health Organization (WHO), including serving as Chair of WHO’s Advisory Committee on influenza composition. From 1985 to 2002, Dr. Schild was Scientific Director of the National Institute for Biological Standards and Control (NIBSC) and a member of the National Biological Standards Board in the United Kingdom. He currently serves on the Boards of Directors of the International Association for Biologicals (IABS), the International Society for Influenza and other Respiratory Virus Diseases (isirv) and the UK Health Protection Agency. |
Jennifer Kmiec, Vice President, Business Development & Marketing | Ms. Kmiec has over 18 years of marketing, product management and operations experience in start-up biotechnology companies. Most recently, she was Vice President of Marketing for Athena Biotechnologies. Ms. Kmiec received her MBA from the University of California, Davis. She also holds a B.S. degree in Biology and began her career as a virologist. Ms. Kmiec currently serves on the Boards of Directors of the Delaware BioScience Association and BioStrategy Partners. |
|